全文获取类型
收费全文 | 1341篇 |
免费 | 2篇 |
国内免费 | 1篇 |
专业分类
财政金融 | 242篇 |
工业经济 | 87篇 |
计划管理 | 338篇 |
经济学 | 446篇 |
综合类 | 9篇 |
运输经济 | 7篇 |
旅游经济 | 2篇 |
贸易经济 | 117篇 |
农业经济 | 28篇 |
经济概况 | 68篇 |
出版年
2023年 | 4篇 |
2022年 | 5篇 |
2020年 | 1篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2015年 | 9篇 |
2014年 | 36篇 |
2013年 | 20篇 |
2012年 | 59篇 |
2011年 | 76篇 |
2010年 | 31篇 |
2009年 | 26篇 |
2008年 | 53篇 |
2007年 | 83篇 |
2006年 | 82篇 |
2005年 | 120篇 |
2004年 | 89篇 |
2003年 | 74篇 |
2002年 | 61篇 |
2001年 | 59篇 |
2000年 | 65篇 |
1999年 | 20篇 |
1998年 | 31篇 |
1997年 | 33篇 |
1996年 | 24篇 |
1995年 | 23篇 |
1994年 | 16篇 |
1993年 | 18篇 |
1992年 | 25篇 |
1991年 | 31篇 |
1990年 | 27篇 |
1989年 | 10篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 9篇 |
1985年 | 8篇 |
1984年 | 20篇 |
1983年 | 17篇 |
1982年 | 7篇 |
1981年 | 16篇 |
1980年 | 11篇 |
1979年 | 10篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1975年 | 6篇 |
1973年 | 1篇 |
排序方式: 共有1344条查询结果,搜索用时 797 毫秒
101.
102.
103.
104.
105.
106.
Lowes R 《Medical economics》2004,81(18):52-4, 56, 58 passim
107.
108.
MacKenzie R 《Journal of insurance medicine (New York, N.Y.)》2001,33(1):106-109
The electrocardiogram (ECG) is a valuable screening tool for increased risk in underwriting life insurance applicants. This article discusses a recently described ECG pattern associated with a high risk of sudden unexpected death. 相似文献
109.
Titcomb C Braun R Roudebush B Mast J Woodman H;Mortality Morbidity Liaison Committee of the Society of Actuaries American Academy of Insurance Medicine Academy of Life Underwriting 《Journal of insurance medicine (New York, N.Y.)》2001,33(3):277-289
Evaluation of applicants for life insurance who have elevations of their liver function tests or an increased probability of alcohol abuse has always been difficult for underwriters. This paper reports the results of an intercompany study in which the pooled mortality experience of a group of insureds with evidence of alcohol abuse, an adverse driving record or elevations of the liver transaminases or gamma-glutamyl transferase is summarized. 相似文献
110.
The curse of the superstar CEO 总被引:1,自引:0,他引:1
Khurana R 《Harvard business review》2002,80(9):60-6, 125
When struggling companies look for a new chief executive today, the one quality they prize above all others is charisma. But once they've recruited a larger-than-life leader, they often find that their troubles only get worse. Indeed, as the author's new research painfully reveals, the widespread belief in the powers of charismatic CEOs can be problematic. Why? First, Khurana says, there's no conclusive evidence that charismatic leadership affects an organization's performance. And yet--as Kodak's story over the past decade reveals--when a company is faltering, boards feel compelled to oust the incumbent chief executive and bring in a corporate savior. Second, the insistence on finding a charismatic leader, combined with the undefinable nature of charisma, results in selection processes that are overly conservative and even irrational. Boards end up considering only candidates who have already achieved the rank of CEO or president at a high-performing, high-profile company, even if they are not right for the job. Third, charismatic leaders deliberately destabilize organizations. This can result in a more vibrant company, as it did at General Electric during Jack Welch's tenure, but it can also leave a troubled legacy for the organization to overcome, as GE, Ford, and Enron have all found. Faith in a company, a product, or an idea can unleash tremendous innovation and productivity. But the extravagant hopes invested in charismatic CEOs resemble not mature faith but a belief in magic. If we are willing to reconsider our notion of leadership, this age of faith can be followed by an era of faith and reason. 相似文献